Realizing flexible bioelectronic medicines for accessing the peripheral nerves - technology considerations.
Vasiliki GiagkaWouter A SerdijnPublished in: Bioelectronic medicine (2018)
Patients suffering from conditions such as paralysis, diabetes or rheumatoid arthritis could in the future be treated in a personalised manner using bioelectronic medicines (BEms) (Nat Rev Drug Discov 13:399-400, 2013, Proc Natl Acad Sci USA 113:8284-9, 2016, J Intern Med 282:37-45, 2017). To deliver this personalised therapy based on electricity, BEms need to target various sites in the human body and operate in a closed-loop manner. The specific conditions and anatomy of the targeted sites pose unique challenges in the development of BEms. With a focus on BEms based on flexible substrates for accessing small peripheral nerves, this paper discusses several system-level technology considerations related to the development of such devices. The focus is mainly on miniaturisation and long-term operation. We present an overview of common substrate and electrode materials, related processing methods, and discuss assembly, miniaturisation and long-term stability issues.
Keyphrases
- rheumatoid arthritis
- newly diagnosed
- end stage renal disease
- type diabetes
- ejection fraction
- cardiovascular disease
- endothelial cells
- chronic kidney disease
- prognostic factors
- emergency department
- chemotherapy induced
- current status
- systemic lupus erythematosus
- bone marrow
- pluripotent stem cells
- carbon nanotubes
- adverse drug
- patient reported
- structural basis